Simon Schwartz Navarro Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools. Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services LinkedIn Twitter Orcid Simon Schwartz Navarro LinkedIn Twitter Orcid Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools.
Currently acting as Strategy director of biobanking and bioresources at Vall d'hebron Campus. President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine. Former director general of the Blood and Tissue Banc of Catalonia. Former director of CIBBIM-Nanomedicine. Former scientific associate director of CIBER-BBN and coordinator of technology transfer. Former director assistance of translational research at VHIR. H-index of 40, with more that 115 high impact publications and 17 transferred patents. Co-founder of 3 biotech companies (i.e, Bsure Medical ltd). Science Advisor of the European Nanomedicine Characterization Laboratory (EU-NCL). Member of the editorial Board of Precision Nanomedicine, J. Nanotechnology and of J. of Nanotheranostics. Former editorial Board member of Eur. J. Nanomedicine and Nanomedicine-NBM.
Projects Nuevos transductores para Kras y BRAF en cáncer colorectal con inestabilidad de microsálites esporádico y hereditario: diferencias de activación según el entorno molecular tumoral. IP: Simon Schwartz Navarro Collaborators: Eloy Espín Basany Funding agency: Instituto de Salud Carlos III Funding: 97580 Reference: PI050304 Duration: 01/01/2006 - 31/12/2008 Oncologia Molecular i Envelliment IP: Simon Schwartz Navarro Collaborators: Diego Arango Corro, Alberto Plaja Rustein, Teresa Vendrell Bayona, Manuel Armengol Carrasco, Eloy Espín Basany Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 36600 Reference: 2005SGR 00076 Duration: 01/01/2006 - 31/12/2008 Papel funcional de los receptores con actividad quinasa EPH y sus ligandos en el cáncer colorectal IP: Simon Schwartz Navarro Collaborators: Diego Arango Corro, Miriam Izquierdo Sans Funding agency: Instituto de Salud Carlos III Funding: 153010.09 Reference: MS05/00256 Duration: 01/03/2006 - 28/02/2012 Detección de nuevos genes de respuesta a radiaciones ionizantes y quimioterápicos mediante oligo chip-microarrays y ensayos de sensibilidad tumoral al tratamiento mediante inhibición por siRNA IP: Simon Schwartz Navarro Collaborators: - Funding agency: Fundació Institut de Recerca HUVH Funding: 13200 Reference: PRED/IR-HUVH/17/2003 Duration: 01/01/2004 - 31/12/2007 Pagination First page « Previous page ‹ … Page 7 Page 8 Current page 9 Page 10 Page 11 Next page › Last page »
